To highlight ongoing work in the STI vaccine and diagnostic research and development (R&D) field and identify gaps, AVAC published its first STI resource tracking report. This report examines disbursements by the U.S. National Institutes of Health and the Bill & Melinda Gates Foundation for vaccine and diagnostic R&D among seven pathogens: chlamydia, genital herpes, gonorrhea, hepatitis B, human papillomavirus (HPV), syphilis, and trichomoniasis. With the NIH and the Gates Foundation being the largest investors across a vast range of global health R&D areas, this report sets a solid foundation for collecting global STI vaccine and diagnostics investments in future reports.
